EDGAR Filing Documents for 0001274644-13-000044

Form 8-K/A - Current report: [Amend]

SEC Accession No. 0001274644-13-000044

Filing Date

2013-09-27

Accepted

2013-09-27 17:23:30

Documents

Period of Report

2013-07-15

Items

Item 2.05: Cost Associated with Exit or Disposal Activities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K /A	a8-kaocera06302013.htm	8-K/A	51942
2	EXHIBIT 10.1	exhibit101kureharestatedli.htm	EX-10.1	210567
3	EXHIBIT 10.2	exhibit102kurehaagreement.htm	EX-10.2	28155
4	EXHIBIT 10.3	exhibit103kurehacommercial.htm	EX-10.3	138523
5	EXHIBIT 10.4	exhibit104kurehaclinicalma.htm	EX-10.4	159068
6	EXHIBIT 10.5	exhibit105ucllicenseagreem.htm	EX-10.5	565638
7	EXHIBIT 23.1	exhibit231proq2a01consent.htm	EX-23.1	4876
8	EXHIBIT 99.1	exhibit991form8-ka.htm	EX-99.1	406866
9	EXHIBIT 99.2	exhibit992form8-ka.htm	EX-99.2	756510
10	EXHIBIT 99.3	exhibit993form8-ka.htm	EX-99.3	241447
	Complete submission text file	0001274644-13-000044.txt		2564833

Mailing Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130

Business Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130 858-436-3900

Ocera Therapeutics, Inc. (Filer) CIK: 0001274644 (see all company filings)